During the past decade, Instytut Diabetologii Sp. z o.o conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instytut Diabetologii Sp. z o.o" are "Autoimmune Diabetes" (1 trials), "Autoimmune Diseases" (1 trials), "Diabetes" (1 trials), "Diabetes Mellitus" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Instytut Diabetologii Sp. z o.o" in a lesser frequency.

Most popular intervention types in "Instytut Diabetologii Sp. z o.o" are "Drug" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Colecalciferol 2000 IU" (1 trials), "Dulaglutide" (1 trials), "Insulin Degludec" (1 trials), "Insulin Glargine" (1 trials) and "Insulin Lispro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instytut Diabetologii Sp. z o.o" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instytut Diabetologii Sp. z o.o". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instytut Diabetologii Sp. z o.o, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instytut Diabetologii Sp. z o.o, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".